[PDF][PDF] 基于仿生DNA 酶的肿瘤诊疗研究进展
王胜峰， 周文虎 - PROGRESS IN PHARMACEUTICAL SCIENCES, 2021 - pps.cpu.edu.cn
… 细胞后有效激活DNA 酶沉默Survivin 基因以提高肿瘤细胞对… -shell nanoparticles co-delivery
DOX and DNAzyme for tumor … for chemo-gene combinatorial treatment of cancer[J/OL]. Int J …
DOX and DNAzyme for tumor … for chemo-gene combinatorial treatment of cancer[J/OL]. Int J …
RNA 药物递送系统抗三阴性乳腺癌的研究进展
刘恺悦， 李亚平， 王爱萍， 郎天群 - 药学进展, 2024 - pps.cpu.edu.cn
… 的亲 水官能团帮助其与survivin siRNA 产生静电作用形 成Dox survivin siRNA 纳米载体(DLP
/… A combinatorial delivery of survivin targeted siRNA using cancer selective nanoparticles for …
/… A combinatorial delivery of survivin targeted siRNA using cancer selective nanoparticles for …
[PDF][PDF] 层层自组装纳米药物载体在癌症治疗中的研究进展
王沛， 刘源岗， 王士斌 - 科学通报, 2017 - researchgate.net
… Curcumin targets folfox-surviving colon cancer cells via … mesoporous silica nanoparticles
against tumor cell proliferation. … and combination of driving force and other parameters through …
against tumor cell proliferation. … and combination of driving force and other parameters through …
[HTML][HTML] 阳离子碳点在癌症诊断和基因治疗一体化中的研究进展
YUE Lin-jun, WEI Ying-ying, FAN Jiang-bo, C Lin… - 新型炭材料, 2021 - xxtcl.sxicc.ac.cn
… used as good targeting carriers for imaging cancer and gene … -803 cells treated with
CCDs@Survivin siRNA for 48 h. (1−3) … emission for selective bioimaging and gene delivery[J]. …
CCDs@Survivin siRNA for 48 h. (1−3) … emission for selective bioimaging and gene delivery[J]. …
氧化还原响应型聚合物在核酸药物递送系统中的应用研究进展
王薪默， 曾朝旺， 陈旺， 刘潇璇， 朱丹丹 - 药学进展, 2022 - pps.cpu.edu.cn
… deliver nucleic acid drugs safely and effectively, especially to achieve on-demand delivery
to target … 法与siRNA 形成一类GSH 响应的壳核型siRNA 递 送系统.该体系具有较高的GSH 响应…
to target … 法与siRNA 形成一类GSH 响应的壳核型siRNA 递 送系统.该体系具有较高的GSH 响应…
基于仿生DNA 酶的肿瘤诊疗研究进展
王胜峰， 周文虎 - 药学进展, 2021 - pps.cpu.edu.cn
… 细胞后有效激活DNA 酶沉默Survivin 基因以提高肿瘤细胞对… -shell nanoparticles co-delivery
DOX and DNAzyme for tumor … for chemo-gene combinatorial treatment of cancer[J/OL]. Int J …
DOX and DNAzyme for tumor … for chemo-gene combinatorial treatment of cancer[J/OL]. Int J …
蜂王浆主蛋白(MRJPs) 作为灭活胎牛血清(FBS) 替代品培养人体细胞的效果评价
D Chen, X Xin, H Qian, Z Yu, L Shen - Journal of Zhejiang University …, 2016 - Springer
… , indicating a selectivity of MRJPs on … in combination with different cytokines on cell viability
remain unclear. Therefore, in this study we examined the effects of the MRJPs in combination …
remain unclear. Therefore, in this study we examined the effects of the MRJPs in combination …
靶向β 分泌酶的神经干细胞RNA 干涉(RNAi) 治疗阿尔茨海默病
Z Liu, S Li, Z Liang, Y Zhao, Y Zhang, Y Yang… - 中国神经再生研究 …, 2013 - sjzsyj.com.cn
… The combination of neural stem cell transplantation and … short hairpin RNA (shRNA) construct
targeting BACE1, the key … cells were passaged, surviving well in subsequent passages. …
targeting BACE1, the key … cells were passaged, surviving well in subsequent passages. …
[HTML][HTML] 肿瘤相关成纤维细胞治疗策略及其递送系统研究进展
袁诗俊， 刘永军， 张娜 - 药学学报, 2022 - html.rhhz.net
… nano-carriers for CAFs-targeting cancer therapies, in order to … 肿瘤细胞抗凋亡蛋白Bcl-2和
Survivin上调从而产生耐药性等; 第… “陷阱”分子的质粒DNA或递送siRNA, 该策略切断了CAFs与肿瘤…
Survivin上调从而产生耐药性等; 第… “陷阱”分子的质粒DNA或递送siRNA, 该策略切断了CAFs与肿瘤…
蜂王浆主蛋白(MRJPs) 作为灭活胎牛血清(FBS) 替代品培养人体细胞的效果评价
XX Di Chen, H Qian, Z Yu, L Shen… - Journal of Zhejiang …, 2016 - jzus.zju.edu.cn
… using MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) assay. The
proliferation activity of the combination … 231 cells, indicating a selectivity of MRJPs on cell types. …
proliferation activity of the combination … 231 cells, indicating a selectivity of MRJPs on cell types. …